Related Experiment Video
Updated: Sep 19, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Inflammation-related polymorphisms IFNG-AS1 rs1558744 and CCAT2 rs6983267: Potential risk factors for ulcerative
Dilek Sari-Tiric1, Seda Orenay-Boyacioglu2, Elmas Kasap3
1School of Medicine, Department of Endocrinology and Metabolic Diseases, Atatürk University, Erzurum, Türkiye.
Polymorphisms in IFNG-AS1 and CCAT2 genes may increase the risk of developing ulcerative colitis (UC). This study investigated inflammation-related long non-coding RNA (lncRNA) gene variants in UC patients and healthy controls.
Area of Science:
- Genetics
- Molecular Biology
- Gastroenterology
Background:
- Long non-coding RNAs (lncRNAs) are implicated in inflammatory processes.
- The role of lncRNAs in ulcerative colitis (UC) pathogenesis is not fully understood.
- Investigating lncRNA polymorphisms may reveal insights into UC development.
Purpose of the Study:
- To determine the association between inflammation-related lncRNA polymorphisms and UC.
- To explore the potential role of these genetic variations in UC pathogenesis.
Main Methods:
- Case-control study involving 73 UC patients and 73 healthy controls.
- Genotyping of specific lncRNA polymorphisms (ANRIL, IFNG-AS1, LINC01430, LOC101926945, CCAT2) using Fluidigm SNP Type.
- Analysis of genotype and allele frequencies in relation to UC status.
Main Results:
- Statistically significant differences in genotype distributions for IFNG-AS1 (rs1558744) and CCAT2 (rs6983267) polymorphisms between UC patients and controls (p=0.042, p=0.033).
- Significant allele frequency difference for IFNG-AS1 rs1558744 polymorphism (p=0.040).
- No significant associations found between polymorphisms and UC disease location, activity, or duration.
Conclusions:
- IFNG-AS1 rs1558744 and CCAT2 rs6983267 polymorphisms are potential risk factors for UC development.
- Further research is warranted to elucidate the precise mechanisms.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Ulcerative Colitis in IBD
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

